{"text": ["Top", "Ranked", "Income", "Stocks", "to", "Buy", "for", "May", "21st"], "created_at": "2019-05-21 14:16:08"}
{"text": ["3", "Top", "Dividend", "Stocks", "to", "Buy", "Right", "Now"], "created_at": "2019-05-21 14:10:17"}
{"text": ["3", "Top", "Dividend", "Stocks", "to", "Buy", "Right", "Now"], "created_at": "2019-05-21 14:10:17"}
{"text": ["Better", "Buy:", "AbbVie", "vs.", "Pfizer"], "created_at": "2019-05-21 14:08:39"}
{"text": ["Better", "Buy:", "AbbVie", "vs.", "Pfizer"], "created_at": "2019-05-21 14:08:39"}
{"text": ["Better", "Buy:", "AbbVie", "vs.", "Pfizer"], "created_at": "2019-05-21 13:00:00"}
{"text": ["AbbVie", "Launches", "ORILISSA\u2122", "(elagolix)", "200", "mg", "BID", "Dose", "for", "the", "Treatment", "of", "Moderate", "to", "Severe", "Pain", "Associated", "with", "Endometriosis"], "created_at": "2019-05-21 12:00:00"}
{"text": ["Top", "Ranked", "Income", "Stocks", "to", "Buy", "for", "May", "21st"], "created_at": "2019-05-21 11:47:11"}
{"text": ["3", "Top", "Dividend", "Stocks", "to", "Buy", "Right", "Now"], "created_at": "2019-05-21 11:15:00"}
